Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis

Abstract Background There are conflicting findings regarding the risk of acute kidney injury (AKI) and mortality with vancomycin/piperacillin-tazobactam combination (VPT) and vancomycin/meropenem (VM). The aim of this meta-analysis was to compare the risk of AKI and mortality between VPT and VM. Met...

Descripció completa

Dades bibliogràfiques

Autors principals:	Abdulmajeed M. Alshehri, Majed S. Al Yami, Atheer Aldairem, Lama Alfehaid, Abdulaali R. Almutairi, Omar A. Almohammed, Amal Mohammad Badawoud
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-01-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Vancomycin Beta-lactams Piperacillin-tazobactam Meropenem Acute kidney injury Nephrotoxicity
Accés en línia:	https://doi.org/10.1186/s12879-024-10227-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!